A Minnesota lab built a synthetic cell that grew and divided for five generations.
A University of Minnesota chemistry lab assembled a cell from non-living chemical parts and watched it eat, grow, and divide for five generations in a flask. The synthetic cell, nicknamed SpudCell by its creators, is, according to Quanta Magazine, the first cell built entirely from non-living chemical parts that grows and divides on its own. The chemist behind the work, Kate Adamala, has set a personal deadline: by 2030, she wants the cell to replicate continuously, the threshold she says would qualify it as "alive."
That is a personal benchmark, not a community forecast. In a long Asimov Press interview, Adamala frames the 2030 date as her lab's working list, a set of engineering bottlenecks her team has to clear before continuous self-replication is possible. The five-generation milestone, reported in a bioRxiv preprint and described by the University of Minnesota, is real. Whether the field can push it to perpetuity inside four years is a separate question, and outside synthetic biologists have not signed onto Adamala's deadline.
Continuous replication is, in Adamala's framing, an engineering problem rather than a metaphysical one. A cell has to harvest raw materials from its environment, rebuild its own molecular machinery, and split in two without losing the genetic information that lets the next generation do the same. SpudCell can already eat and grow. The team has not yet closed the loop on genome inheritance and division in the same package.
The same capability that makes SpudCell a milestone is, in Adamala's telling, also the prerequisite for the construction she most wants to prevent. "Mirror life" is the term for organisms built from mirror-image versions of the molecules life on Earth uses. The DNA in every cell, the proteins, the sugars, all of them have a handedness, a chirality, and every Earth organism reads only one of the two possible orientations. A mirror bacterium, according to a 2024 warning signed by dozens of scientists, would be invisible to the immune systems and antiviral defenses that evolved to recognize the natural-handed version. A Stanford technical report on mirror-bacteria feasibility and risks calls the potential antimicrobial resistance implications unprecedented in magnitude.
Adamala is among the most prominent scientific voices against mirror-bacteria research, and her work on synthetic cells from scratch sits in the same funding ecosystem as the policy debate around it. Bottom-up synthetic biology, the field of building cells from non-living parts, is the same toolkit that would be needed to assemble a mirror organism. Adamala is publicly arguing that the field should learn how to do this so it can decide, ahead of time, what should not be done.
In the same Asimov Press interview, Adamala describes a shift in her own stance over the course of the conversation. The earlier instinct, that mirror-biology work should be preemptively banned, gave way to a more layered view. The capability, in her telling, is coming whether or not any single lab drives it, and the responsible move is to build the science in the open, where its risks can be named and its off-ramp can be negotiated, rather than to hope no one figures it out.
The 2030 deadline, then, is not really a forecast. It is a working list and a public test. If Adamala's lab crosses it, the field will have a continuously self-replicating synthetic cell to argue about, and a chemist on record arguing that the same technology should be used to build the off-ramp for the next, more dangerous step. If it does not, the five-generation cell is still on the shelf, and the question of who gets to call it "alive" is still open.